Honorary Professor Geoffrey Hill
Honorary Professor

Geoffrey Hill

Email: 

Background

Professor Geoff Hill MBChB MD BHB FRCPA FRACP geoffH@qimr.edu.au

NHMRC Australia and QLD Health Senior Clinical Research Fellow

Coordinator, Cancer Programme, QIMR Berghofer

Head, Bone Marrow Transplantation Laboratory, QIMR Berghofer

Director of Research, Cancer Care Services, Royal Brisbane & Womens’ Hospital

Bone Marrow Transplant Physician and Haematologist, Royal Brisbane & Womens’ Hospital

Geoff Hill is a medical graduate of the University of Auckland and Haematologist, training in New Zealand, The Dana Farber Cancer Institute in Boston. He is a NHMRC Australia Fellow and his immunology laboratory focuses on the interactions between cytokines, antigen presenting cells and regulatory T cells during transplantation.

Professor Hill was the 2005 Queenslander of the Year and recipient of the Transplantation Society of Australia and New Zealand 2009 Ian McKenzie Award and the 2014 Translational Research Institute National Prize for excellence within basic and clinical research in the transplant field. He was also awarded a Queensland Health Senior Clinical Research Fellowship in 2010 to translate new cytokine and cell based therapies into clinic practice.

Availability

Honorary Professor Geoffrey Hill is:
Available for supervision

Fields of research

Clinical sciences Immunology

Qualifications

  • Bachelor, The University of Auckland
  • Masters (Coursework) of Medicine Surgery, The University of Auckland
  • Doctoral Diploma of Medicine, The University of Auckland
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia

Search Professor Geoffrey Hill’s works on UQ eSpace

310 works between 1996 and 2025
All (310) Journal Article (270) Conference Publication (38) Book Chapter (2)

281 - 300 of 310 works

2003

Journal Article

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation

MacDonald, Kelli P. A., Rowe, Vanessa, Filippich, Cheryl, Thomas, Ranjeny, Clouston, Andrew D., Welply, Joseph K., Hart, Derek N. J., Ferrara, James L. M. and Hill, Geoffrey R. (2003). Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation. Blood, 101 (5), 2033-2042. doi: 10.1182/blood-2002-05-1529

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation

2003

Conference Publication

Progenipoietin-1 and G-CSF expand a novel CD40(neg) APC that induces transplant tolerance through IL-10 producing regulatory T cells

MacDonald, K. P. A., Rowe, V., Thomas, R., Welply, J. K., Woulfe, S., Ferrara, J. L. M. and Hill, G. R. (2003). Progenipoietin-1 and G-CSF expand a novel CD40(neg) APC that induces transplant tolerance through IL-10 producing regulatory T cells. 45th Annual Meeting of the American Society of Hematology, San Diego, CA, United States, 6 - 9 December 2003. Washington, DC, United States: American Society of Hematology.

Progenipoietin-1 and G-CSF expand a novel CD40(neg) APC that induces transplant tolerance through IL-10 producing regulatory T cells

2002

Journal Article

Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis - A missed opportunity for induction CNS prophylaxis

Wellwood, J, Taylor, K, Wright, S, Bentley, M, Hill, G, Phan, H, Norris, D and Livsey, R (2002). Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis - A missed opportunity for induction CNS prophylaxis. Leukemia & Lymphoma, 43 (4), 893-896. doi: 10.1080/10428190290017060

Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis - A missed opportunity for induction CNS prophylaxis

2002

Journal Article

Keratinocyte Growth factor (KGF) in hematology and oncology

MacDonald, KPA and Hill, GR (2002). Keratinocyte Growth factor (KGF) in hematology and oncology. Current Pharmaceutical Design, 8 (5), 395-403. doi: 10.2174/1381612023396104

Keratinocyte Growth factor (KGF) in hematology and oncology

2001

Journal Article

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

Cooke, KR, Gerbitz, A, Crawford, JM, Teshima, T, Hill, GR, Tesolin, A, Rossignol, DP and Ferrara, JLM (2001). LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. Journal of Clinical Investigation, 107 (12), 1581-1589. doi: 10.1172/JCI12156

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

2001

Journal Article

Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation

Teshima, T, Mach, N, Hill, GR, Pan, LY, Gillessen, S, Dranoff, G and Ferrara, JLM (2001). Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer Research, 61 (1), 162-171.

Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation

2000

Journal Article

Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammation

Cooke, KR, Hill, GR, Gerbitz, A, Kobzik, L, Martin, TR, Crawford, JM, Brewer, JP and Ferrara, JLM (2000). Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammation. Journal of Immunology, 165 (11), 6612-6619. doi: 10.4049/jimmunol.165.11.6612

Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammation

2000

Journal Article

Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation

Cooke, KR, Hill, GR, Gerbitz, A, Kobzik, L, Martin, TR, Crawford, JM, Brewer, JP and Ferrara, JLM (2000). Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation, 70 (2), 272-279. doi: 10.1097/00007890-200007270-00006

Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation

2000

Journal Article

The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation

Hill, GR and Ferrara, JLM (2000). The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood, 95 (9), 2754-2759.

The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation

2000

Journal Article

G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient

Reddy, , Hill, GR, Pan, LY, Gerbitz, A, Teshima, T, Brinson, Y and Ferrara, JLM (2000). G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation, 69 (4), 691-693. doi: 10.1097/00007890-200002270-00041

G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient

2000

Journal Article

The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity

Hill, GR, Teshima, T, Rebel, , Krijanovski, OI, Cooke, KR, Brinson, YS and Ferrara, JLM (2000). The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity. Journal of Immunology, 164 (2), 656-663. doi: 10.4049/jimmunol.164.2.656

The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity

2000

Journal Article

Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide

Snowden, JA, Hill, GR, Hunt, P, Carnoutsos, S, Spearing, RL, Espiner, E and Hart, DNJ (2000). Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide. Bone Marrow Transplantation, 26 (3), 309-313. doi: 10.1038/sj.bmt.1702507

Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide

1999

Journal Article

Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level

Rebel, , Hartnett, S, Hill, GR, Lazo-Kallanian, SB, Ferrara, JLM and Sieff, CA (1999). Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level. Journal of Experimental Medicine, 190 (10), 1493-1503. doi: 10.1084/jem.190.10.1493

Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level

1999

Journal Article

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia

Hill, GR, Teshima, T, Gerbitz, A, Pan, LY, Cooke, KR, Brinson, YS, Crawford, JM and Ferrara, JLM (1999). Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. Journal of Clinical Investigation, 104 (4), 459-467. doi: 10.1172/JCI6896

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia

1999

Journal Article

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation

Teshima, T, Hill, GR, Pan, LY, Brinson, YS, van den Brink, MRM, Cooke, KR and Ferrara, JLM (1999). IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. Journal of Clinical Investigation, 104 (3), 317-325. doi: 10.1172/JCI7111

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation

1999

Journal Article

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease

Krijanovski, OI, Hill, GR, Cooke, KR, Teshima, T, Crawford, JM, Brinson, YS and Ferrara, JLM (1999). Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood, 94 (2), 825-831.

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease

1999

Journal Article

Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease

Pan, LP, Teshima, T, Hill, GR, Bungard, D, Brinson, YS, Reddy, VS, Cooke, KR and Ferrara, LM (1999). Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood, 93 (12), 4071-4078.

Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease

1999

Journal Article

Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation

Hill, GR, Cooke, KR, Brinson, YS, Bungard, D and Ferrara, JLM (1999). Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation, 67 (11), 1478-1480. doi: 10.1097/00007890-199906150-00015

Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation

1999

Journal Article

Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma

Hart, D. N. J. and Hill, G. R. (1999). Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma. Immunology and Cell Biology, 77 (5), 451-459. doi: 10.1046/j.1440-1711.1999.00859.x

Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma

1998

Journal Article

Congenital dyserythropoiesis with intererythroblastic chromatin bridges and ultrastructurally-normal erythroblast heterochromatin: a new disorder

Wickramashinghe, SN, Spearing, RL and Hill, GR (1998). Congenital dyserythropoiesis with intererythroblastic chromatin bridges and ultrastructurally-normal erythroblast heterochromatin: a new disorder. British Journal of Haematology, 103 (3), 831-834.

Congenital dyserythropoiesis with intererythroblastic chromatin bridges and ultrastructurally-normal erythroblast heterochromatin: a new disorder

Current funding

  • 2024 - 2027
    Harnessing the gut microbiome to improve stem cell transplant outcome (NHMRC Ideas 2023 Administered by The Council of the Queensland Institute of Medical Research)
    Queensland Institute of Medical Research
    Open grant

Past funding

  • 2015 - 2016
    Developing new ways to predict infection in patients undergoing chemotherapy and bone marrow transplantation
    UQ Academic Title Holder Research Fund
    Open grant
  • 2010 - 2014
    Immunological therapies for cancer, chronic infection and autoimmunity
    NHMRC Program Grant
    Open grant
  • 2005 - 2009
    Immunological therapies for cancer and autoimmunity
    NHMRC Program Grant
    Open grant
  • 2003 - 2004
    Migration And Differentiation Of Dendritic Cells And Monocytes In Inflammatory Arthritis
    NHMRC Project Grant
    Open grant

Availability

Honorary Professor Geoffrey Hill is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Completed supervision

Enquiries

For media enquiries about Honorary Professor Geoffrey Hill's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au